Showing results (161-170 of 168) with videos related to
Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 168 results.
Plos One|May 1, 2009
Characteristics of HIV-1 discordant couples enrolled in a trial of HSV-2 suppression to reduce HIV-1 transmission: the partners studyJairam R Lingappa, Erin Kahle, Nelly Mugo, et al.Lancet (London, England)|February 16, 2010
Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trialJairam R Lingappa, Jared M Baeten, Anna Wald, et al.Frontiers in Immunology|October 2, 2025
No evidence of MMR induced trained immunity to prevent SARS COV2: results from a multi-centre RCTSinead Delany-Moretlwe, Hakim-Moulay Dehbi, Izukanji Sikazwe, et al.Journal of Clinical Immunology|August 14, 2021
Genetic Analysis of a Cohort of 275 Patients with Hyper-IgE Syndromes and/or Chronic Mucocutaneous CandidiasisNatalie Frede, Jessica Rojas-Restrepo, Andrés Caballero Garcia de Oteyza, et al.Medrxiv : the Preprint Server for Health Sciences|December 4, 2023
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participantsCatherine Riou, Jinal N Bhiman, Yashica Ganga, et al.PLOS Global Public Health|April 11, 2024
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participantsCatherine Riou, Jinal N Bhiman, Yashica Ganga, et al.Cancer Discovery|December 18, 2024
Stratified Medicine Pediatrics: Cell-Free DNA and Serial Tumor Sequencing Identifies Subtype-Specific Cancer Evolution and Epigenetic StatesSally L George, Claire Lynn, Reda Stankunaite, et al.The New England Journal of Medicine|December 2, 2020
Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results, Hongchao Pan, Richard Peto, et al.Pageof 17